Outlook Therapeutics Inc. (OTLK) NASDAQ
$11.94 2.57 (27.43%)
Market Cap: $2.44B
As of 03/28/24 04:00 PM EDT. Market closed.
Outlook Therapeutics Inc. (OTLK)
NASDAQ
$11.94
2.57 (27.43%)
Market Cap: $2.44B
As of 03/28/24 04:00 PM EDT. Market closed.
overview oncobiologics is a pure-play complex biosimilar company focused on technically challenging and commercially attractive monoclonal antibodies (mabs), in the therapeutic areas of immunology and oncology. our strategy is to cost-effectively develop technically challenging biosimilars on an accelerated timeline, which we believe is fundamental to our success and positions us to be a leading ... read more
overview oncobiologics is a pure-play complex biosimilar company focused on technically challenging and commercially attractive monoclonal antibodies (mabs), in the therapeutic areas of immunology and oncology. our strategy is to cost-effectively develop technically challenging biosimilars on an accelerated timeline, which we believe is fundamental to our success and positions us to be a leading biosimilar company. we have leveraged our team’s biopharmaceutical expertise to establish fully integrated in-house development and manufacturing capabilities, which we refer to as our biosymphony™ platform. oncobiologics’ platform addresses the numerous complex technical and regulatory challenges in developing and commercializing mab biosimilars. pipeline oncobiologics is actively working on eight biosimilar candidates. the company’s most advanced assets, ons-3010 (a biosimilar of humira®) and ons-1045 (a biosimilar of avastin®) have both successfully completed phase i trials and phase 3 t read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Evanson Jeff | CHIEF COMMERCIAL OFFICER | Mar 07, 2024 | Buy | $0.42 | 62,484 | 26,243 | 808,459 | Mar 11, 2024, 04:43 PM |
Dagnon Terry | Chief Operations Officer | Apr 20, 2023 | Sale | $1.13 | 520,000 | 590,200 | 653,058 | Apr 21, 2023, 09:05 PM |
Evanson Jeff | Chief Commercial Officer | Jan 20, 2023 | Sale | $1.11 | 267,000 | 296,370 | 745,975 | Jan 24, 2023, 08:08 PM |
Evanson Jeff | Chief Commercial Officer | Jan 18, 2023 | Sale | $1.25 | 33,738 | 42,173 | 1,116,230 | Jan 19, 2023, 08:05 PM |
Evanson Jeff | Chief Commercial Officer | Jan 17, 2023 | Sale | $1.31 | 27,162 | 35,582 | 1,149,968 | Jan 19, 2023, 08:05 PM |
Evanson Jeff | Chief Commercial Officer | Jan 19, 2023 | Sale | $1.22 | 103,255 | 125,971 | 1,012,975 | Jan 19, 2023, 08:05 PM |
Sukhtian Ghiath M. | Director | Dec 28, 2022 | Option Exercise | $0.88 | 14,230,418 | 12,500,000 | 70,047,204 | Dec 29, 2022, 05:01 PM |
Sukhtian Faisal Ghiath | Director | Oct 07, 2022 | Buy | $1.29 | 30,000 | 38,700 | 68,000 | Oct 11, 2022, 05:09 PM |
Haddadin Yezan Munther | Director | Oct 07, 2022 | Buy | $1.27 | 3,600 | 4,572 | 63,343 | Oct 11, 2022, 05:05 PM |
Haddadin Yezan Munther | Director | Oct 06, 2022 | Buy | $1.29 | 29,743 | 38,368 | 59,743 | Oct 11, 2022, 05:05 PM |
HILZINGER KURT J | Director | Oct 04, 2022 | Buy | $1.29 | 95,541 | 123,248 | 457,455 | Oct 05, 2022, 04:43 PM |
HILZINGER KURT J | Director | Oct 05, 2022 | Buy | $1.23 | 15,662 | 19,264 | 473,117 | Oct 05, 2022, 04:43 PM |
HILZINGER KURT J | Director | Oct 03, 2022 | Buy | $1.25 | 41,798 | 52,248 | 361,914 | Oct 03, 2022, 05:19 PM |
HILZINGER KURT J | Director | Sep 30, 2022 | Buy | $1.26 | 33,199 | 41,831 | 320,116 | Oct 03, 2022, 05:19 PM |
HILZINGER KURT J | Director | Sep 29, 2022 | Buy | $1.19 | 13,800 | 16,422 | 286,917 | Oct 03, 2022, 05:19 PM |
Dagnon Terry | Chief Operating Officer | Jun 21, 2022 | Buy | $1.05 | 10,000 | 10,500 | 1,173,058 | Jun 23, 2022, 05:08 PM |
TRENARY C RUSSELL III | CEO and President | Jun 21, 2022 | Buy | $1.06 | 19,925 | 21,120 | 54,925 | Jun 23, 2022, 05:07 PM |
HILZINGER KURT J | Director | Mar 01, 2022 | Buy | $1.69 | 27,708 | 46,827 | 273,117 | Mar 03, 2022, 05:30 PM |
HILZINGER KURT J | Director | Feb 28, 2022 | Buy | $1.60 | 6,000 | 9,600 | 245,409 | Feb 28, 2022, 05:57 PM |
HILZINGER KURT J | Director | Feb 24, 2022 | Buy | $1.46 | 41,160 | 60,094 | 239,409 | Feb 28, 2022, 05:57 PM |
HILZINGER KURT J | Director | Feb 23, 2022 | Buy | $1.44 | 79,535 | 114,530 | 198,249 | Feb 23, 2022, 05:42 PM |
HILZINGER KURT J | Director | Feb 22, 2022 | Buy | $1.49 | 95,597 | 142,440 | 118,714 | Feb 23, 2022, 05:42 PM |
Pillai Arun Kumar | Director | Feb 01, 2022 | Option Exercise | $1.25 | 2,500,000 | 3,125,000 | 22,982,529 | Feb 01, 2022, 05:09 PM |
Sukhtian Ghiath M. | Director | Feb 01, 2022 | Option Exercise | $1.25 | 2,500,000 | 3,125,000 | 27,982,529 | Feb 01, 2022, 05:05 PM |
TRENARY C RUSSELL III | CEO and President | Dec 06, 2021 | Buy | $1.39 | 25,000 | 34,750 | 35,000 | Dec 06, 2021, 05:27 PM |
Dagnon Terry | Chief Operating Officer | Dec 06, 2021 | Buy | $1.38 | 25,201 | 34,777 | 1,163,058 | Dec 06, 2021, 05:26 PM |
Evanson Jeff | Chief Commercial Officer | Dec 03, 2021 | Buy | $1.34 | 35,200 | 47,168 | 1,177,130 | Dec 06, 2021, 05:25 PM |
Dagnon Terry | Chief Operating Officer | Dec 03, 2021 | Buy | $1.42 | 10,000 | 14,200 | 1,137,857 | Dec 03, 2021, 04:32 PM |
Haddadin Yezan Munther | Director | Dec 02, 2021 | Buy | $1.39 | 10,000 | 13,900 | 30,000 | Dec 02, 2021, 05:09 PM |
Sukhtian Faisal Ghiath | Director | Dec 02, 2021 | Buy | $1.40 | 18,000 | 25,200 | 38,000 | Dec 02, 2021, 05:08 PM |
TRENARY C RUSSELL III | CEO and President | Dec 02, 2021 | Buy | $1.40 | 10,000 | 14,000 | 10,000 | Dec 02, 2021, 05:07 PM |
Sukhtian Ghiath M. | Director | Nov 29, 2021 | Buy | $1.25 | 16,000,000 | 20,000,000 | 27,834,257 | Dec 01, 2021, 07:32 PM |
Haddadin Yezan Munther | Director | Apr 19, 2021 | Buy | $1.82 | 10,000 | 18,200 | 20,000 | Apr 20, 2021, 07:56 PM |
Sukhtian Faisal Ghiath | Director | Apr 19, 2021 | Buy | $1.82 | 10,000 | 18,200 | 20,000 | Apr 20, 2021, 07:55 PM |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Apr 20, 2021 | Buy | $1.83 | 10,000 | 18,300 | 18,926 | Apr 20, 2021, 07:54 PM |
Evanson Jeff | Chief Commercial Officer | Feb 23, 2021 | Sale | $2.09 | 8,554 | 17,861 | 1,141,930 | Feb 25, 2021, 08:52 PM |
Dagnon Terry | Chief Operating Officer | Feb 23, 2021 | Sale | $2.09 | 15,900 | 33,199 | 1,127,857 | Feb 25, 2021, 08:51 PM |
Evanson Jeff | Chief Commercial Officer | Feb 12, 2021 | Sale | $2.55 | 56,973 | 145,281 | 1,150,484 | Feb 17, 2021, 09:14 PM |
Dagnon Terry | Chief Operating Officer | Feb 12, 2021 | Sale | $2.55 | 63,700 | 162,435 | 1,143,757 | Feb 17, 2021, 09:13 PM |
Sukhtian Ghiath M. | Director | Feb 10, 2021 | Option Exercise | $1.00 | 1,013,627 | 1,013,627 | 11,834,257 | Feb 11, 2021, 05:46 PM |
Syntone Ventures LLC | 10% Owner | Feb 03, 2021 | Buy | $1.00 | 3,000,000 | 3,000,000 | 19,823,045 | Feb 04, 2021, 08:54 PM |
Sukhtian Ghiath M. | Director | Feb 02, 2021 | Buy | $1.00 | 8,360,000 | 8,360,000 | 10,820,630 | Feb 02, 2021, 05:32 PM |
Haddadin Yezan Munther | Director | Sep 22, 2020 | Buy | $0.72 | 10,000 | 7,245 | 10,000 | Sep 22, 2020, 05:14 PM |
Sukhtian Faisal Ghiath | Director | Sep 17, 2020 | Buy | $0.67 | 10,000 | 6,731 | 10,000 | Sep 17, 2020, 07:18 PM |
THURMAN RANDY H | Director | Sep 14, 2020 | Buy | $0.62 | 10,000 | 6,200 | 11,875 | Sep 15, 2020, 06:31 PM |
Syntone Ventures LLC | 10% Owner | Jul 15, 2020 | Buy | $1.22 | 823,045 | 1,000,000 | 16,823,045 | Jul 28, 2020, 06:01 PM |
Sukhtian Ghiath M. | Director | Feb 26, 2020 | Option Exercise | $1.02 | 2,460,630 | 2,500,000 | 2,460,630 | Feb 27, 2020, 05:10 PM |
BioLexis Pte Ltd. | Director | Jan 29, 2020 | Option Exercise | $0.23 | 4,657,852 | 1,080,622 | 21,606,437 | Jan 29, 2020, 05:53 PM |
BioLexis Pte Ltd. | Director | Dec 23, 2019 | Option Exercise | $0.23 | 2,909,091 | 674,909 | 16,948,585 | Dec 30, 2019, 05:14 PM |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Sep 18, 2019 | Sale | $1.70 | 1,350 | 2,295 | 8,926 | Oct 15, 2019, 05:08 PM |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Sep 18, 2019 | Sale | $1.70 | 1,350 | 2,295 | 80,863 | Sep 23, 2019, 05:09 PM |
BioLexis Pte Ltd. | Director | Apr 12, 2019 | Option Exercise | $2.75 | 3,636,364 | 10,000,001 | 11,857,676 | Apr 16, 2019, 05:35 PM |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Feb 07, 2019 | Buy | $0.90 | 25,000 | 22,380 | 82,213 | Feb 08, 2019, 08:14 PM |
HILZINGER KURT J | Director | Feb 04, 2019 | Buy | $0.80 | 5,983 | 4,786 | 184,947 | Feb 06, 2019, 05:57 PM |
BioLexis Pte Ltd. | Director | Feb 01, 2019 | Option Exercise | $0.93 | 4,288,624 | 4,000,000 | 65,770,503 | Feb 05, 2019, 04:47 PM |
HILZINGER KURT J | Director | Jan 31, 2019 | Buy | $0.75 | 6,300 | 4,725 | 170,764 | Feb 01, 2019, 06:25 PM |
HILZINGER KURT J | Director | Jan 30, 2019 | Buy | $0.72 | 4,890 | 3,521 | 164,464 | Feb 01, 2019, 06:25 PM |
HILZINGER KURT J | Director | Feb 01, 2019 | Buy | $0.77 | 8,200 | 6,314 | 178,964 | Feb 01, 2019, 06:25 PM |
HILZINGER KURT J | Director | Jan 29, 2019 | Buy | $0.73 | 5,400 | 3,942 | 159,574 | Jan 29, 2019, 07:01 PM |
HILZINGER KURT J | Director | Jan 28, 2019 | Buy | $0.71 | 15,884 | 11,278 | 154,174 | Jan 29, 2019, 07:01 PM |
HILZINGER KURT J | Director | Jan 25, 2019 | Buy | $0.69 | 10,828 | 7,471 | 138,290 | Jan 29, 2019, 07:01 PM |
HILZINGER KURT J | Director | Jan 23, 2019 | Buy | $0.67 | 2,266 | 1,518 | 127,462 | Jan 24, 2019, 07:51 PM |
HILZINGER KURT J | Director | Jan 22, 2019 | Buy | $0.68 | 10,749 | 7,309 | 125,196 | Jan 24, 2019, 07:51 PM |
HILZINGER KURT J | Director | Jan 17, 2019 | Buy | $0.69 | 2,300 | 1,587 | 114,447 | Jan 18, 2019, 04:51 PM |
HILZINGER KURT J | Director | Jan 16, 2019 | Buy | $0.68 | 800 | 544 | 112,147 | Jan 18, 2019, 04:51 PM |
Mohan Pankaj | Director | Jan 15, 2019 | Buy | $0.68 | 8,000 | 5,440 | 7,064,553 | Jan 17, 2019, 04:45 PM |
HILZINGER KURT J | Director | Jan 15, 2019 | Buy | $0.70 | 2,266 | 1,586 | 111,347 | Jan 16, 2019, 05:31 PM |
HILZINGER KURT J | Director | Jan 14, 2019 | Buy | $0.71 | 4,399 | 3,123 | 109,081 | Jan 16, 2019, 05:31 PM |
HILZINGER KURT J | Director | Jan 09, 2019 | Buy | $0.73 | 2,792 | 2,038 | 98,629 | Jan 11, 2019, 05:18 PM |
HILZINGER KURT J | Director | Jan 10, 2019 | Buy | $0.70 | 6,053 | 4,237 | 104,682 | Jan 11, 2019, 05:18 PM |
HILZINGER KURT J | Director | Jan 08, 2019 | Buy | $0.65 | 6,410 | 4,166 | 95,837 | Jan 08, 2019, 08:13 PM |
HILZINGER KURT J | Director | Jan 07, 2019 | Buy | $0.63 | 5,166 | 3,255 | 89,427 | Jan 08, 2019, 08:13 PM |
HILZINGER KURT J | Director | Jan 04, 2019 | Buy | $0.59 | 6,205 | 3,661 | 84,261 | Jan 08, 2019, 08:13 PM |
HILZINGER KURT J | Director | Jan 02, 2019 | Buy | $0.59 | 1,640 | 968 | 73,856 | Jan 03, 2019, 06:01 PM |
HILZINGER KURT J | Director | Dec 31, 2018 | Buy | $0.59 | 11,349 | 6,696 | 72,216 | Jan 03, 2019, 06:01 PM |
HILZINGER KURT J | Director | Jan 03, 2019 | Buy | $0.59 | 4,200 | 2,478 | 78,056 | Jan 03, 2019, 06:01 PM |
BioLexis Pte Ltd. | Director | Jan 02, 2019 | Option Exercise | $0.93 | 4,288,624 | 4,000,000 | 61,481,879 | Jan 03, 2019, 12:00 AM |
HILZINGER KURT J | Director | Dec 28, 2018 | Buy | $0.52 | 11,910 | 6,193 | 60,867 | Dec 28, 2018, 05:06 PM |
HILZINGER KURT J | Director | Dec 27, 2018 | Buy | $0.51 | 730 | 372 | 48,957 | Dec 28, 2018, 05:06 PM |
HILZINGER KURT J | Director | Dec 26, 2018 | Buy | $0.54 | 5,714 | 3,086 | 48,227 | Dec 28, 2018, 05:06 PM |
HILZINGER KURT J | Director | Dec 24, 2018 | Buy | $0.66 | 1,113 | 735 | 42,513 | Dec 26, 2018, 05:17 PM |
HILZINGER KURT J | Director | Dec 21, 2018 | Buy | $0.65 | 3,600 | 2,340 | 41,400 | Dec 26, 2018, 05:17 PM |
THURMAN RANDY H | Director | Dec 21, 2018 | Buy | $0.68 | 15,000 | 10,251 | 15,000 | Dec 21, 2018, 05:17 PM |
BioLexis Pte Ltd. | Director | Dec 03, 2018 | Option Exercise | $0.93 | 4,288,624 | 4,000,000 | 57,193,255 | Dec 06, 2018, 05:08 PM |
BioLexis Pte Ltd. | Director | Nov 07, 2018 | Option Exercise | $0.93 | 8,577,248 | 7,999,999 | 52,904,631 | Nov 09, 2018, 05:05 PM |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | Sep 18, 2018 | Sale | $0.87 | 10,100 | 8,807 | 57,213 | Sep 18, 2018, 04:56 PM |
Bahrt Kenneth | Chief Medical Officer | Jun 25, 2018 | Sale | $0.85 | 7,700 | 6,507 | 47,120 | Jun 27, 2018, 07:52 PM |
GMS Tenshi Holdings Pte. Ltd | Director | May 14, 2018 | Option Exercise | $0.98 | 6,377,383 | 6,217,949 | 6,377,383 | Jun 25, 2018, 05:22 PM |
GMS Tenshi Holdings Pte. Ltd | Director | Jun 08, 2018 | Option Exercise | $0.98 | 6,377,383 | 6,217,949 | 12,754,766 | Jun 25, 2018, 05:22 PM |
Mohan Pankaj | President & CEO | Jan 04, 2018 | Sale | $1.16 | 62,569 | 72,580 | 7,056,553 | Jan 05, 2018, 04:28 PM |
Mohan Pankaj | President & CEO | Jan 03, 2018 | Sale | $1.18 | 52,108 | 61,487 | 7,119,122 | Jan 05, 2018, 04:28 PM |
Yamashita Elizabeth A. | VP, Regulatory Affairs | Dec 22, 2017 | Sale | $1.13 | 16,170 | 18,272 | 64,648 | Dec 26, 2017, 05:07 PM |
Bahrt Kenneth | Chief Medical Officer | Dec 22, 2017 | Sale | $1.13 | 26,165 | 29,566 | 54,820 | Dec 26, 2017, 05:06 PM |
MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | Dec 22, 2017 | Sale | $1.13 | 15,705 | 17,747 | 50,899 | Dec 26, 2017, 05:05 PM |
KENYON LAWRENCE A | CFO and Secretary | Dec 22, 2017 | Sale | $1.13 | 26,165 | 29,566 | 67,313 | Dec 26, 2017, 05:04 PM |
Mohan Pankaj | President & CEO | Dec 19, 2017 | Sale | $1.14 | 83,608 | 95,313 | 7,171,230 | Dec 20, 2017, 07:55 PM |
Mohan Pankaj | President & CEO | Dec 18, 2017 | Sale | $1.17 | 20,523 | 24,012 | 7,254,838 | Dec 20, 2017, 07:55 PM |
Yamashita Elizabeth A. | VP, Regulatory Affairs | Dec 19, 2017 | Sale | $1.14 | 6,151 | 7,012 | 80,818 | Dec 20, 2017, 07:48 PM |
Yamashita Elizabeth A. | VP, Regulatory Affairs | Dec 18, 2017 | Sale | $1.17 | 1,509 | 1,766 | 86,969 | Dec 20, 2017, 07:48 PM |
HILZINGER KURT J | Director | Jan 23, 2017 | Option Exercise | $0.01 | 12,036 | 120 | 30,554 | Jan 24, 2017, 05:44 PM |
Griffith Donald J. | Director | Nov 23, 2016 | Sale | $3.75 | 1 | 4 | 144,926 | Nov 28, 2016, 09:59 PM |
Gangloff Scott A. | SVP, Development & Mfrg | Nov 11, 2016 | Sale | $3.75 | 37,369 | 140,134 | 78,573 | Nov 14, 2016, 06:36 PM |
MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | Nov 11, 2016 | Sale | $3.75 | 21,367 | 80,126 | 36,604 | Nov 14, 2016, 06:20 PM |
Owner | Relationship | Date | Value($) |
Evanson Jeff | CHIEF COMMERCIAL OFFICER | 03/07/2024 | 26,243 |
Dagnon Terry | Chief Operations Officer | 04/20/2023 | 590,200 |
Evanson Jeff | Chief Commercial Officer | 01/20/2023 | 296,370 |
Evanson Jeff | Chief Commercial Officer | 01/18/2023 | 42,173 |
Evanson Jeff | Chief Commercial Officer | 01/17/2023 | 35,582 |
Evanson Jeff | Chief Commercial Officer | 01/19/2023 | 125,971 |
Sukhtian Ghiath M. | Director | 12/28/2022 | 12,500,000 |
Sukhtian Faisal Ghiath | Director | 10/07/2022 | 38,700 |
Haddadin Yezan Munther | Director | 10/07/2022 | 4,572 |
Haddadin Yezan Munther | Director | 10/06/2022 | 38,368 |
HILZINGER KURT J | Director | 10/04/2022 | 123,248 |
HILZINGER KURT J | Director | 10/05/2022 | 19,264 |
HILZINGER KURT J | Director | 10/03/2022 | 52,248 |
HILZINGER KURT J | Director | 09/30/2022 | 41,831 |
HILZINGER KURT J | Director | 09/29/2022 | 16,422 |
Dagnon Terry | Chief Operating Officer | 06/21/2022 | 10,500 |
TRENARY C RUSSELL III | CEO and President | 06/21/2022 | 21,120 |
HILZINGER KURT J | Director | 03/01/2022 | 46,827 |
HILZINGER KURT J | Director | 02/28/2022 | 9,600 |
HILZINGER KURT J | Director | 02/24/2022 | 60,094 |
HILZINGER KURT J | Director | 02/23/2022 | 114,530 |
HILZINGER KURT J | Director | 02/22/2022 | 142,440 |
Pillai Arun Kumar | Director | 02/01/2022 | 3,125,000 |
Sukhtian Ghiath M. | Director | 02/01/2022 | 3,125,000 |
TRENARY C RUSSELL III | CEO and President | 12/06/2021 | 34,750 |
Dagnon Terry | Chief Operating Officer | 12/06/2021 | 34,777 |
Evanson Jeff | Chief Commercial Officer | 12/03/2021 | 47,168 |
Dagnon Terry | Chief Operating Officer | 12/03/2021 | 14,200 |
Haddadin Yezan Munther | Director | 12/02/2021 | 13,900 |
Sukhtian Faisal Ghiath | Director | 12/02/2021 | 25,200 |
TRENARY C RUSSELL III | CEO and President | 12/02/2021 | 14,000 |
Sukhtian Ghiath M. | Director | 11/29/2021 | 20,000,000 |
Haddadin Yezan Munther | Director | 04/19/2021 | 18,200 |
Sukhtian Faisal Ghiath | Director | 04/19/2021 | 18,200 |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | 04/20/2021 | 18,300 |
Evanson Jeff | Chief Commercial Officer | 02/23/2021 | 17,861 |
Dagnon Terry | Chief Operating Officer | 02/23/2021 | 33,199 |
Evanson Jeff | Chief Commercial Officer | 02/12/2021 | 145,281 |
Dagnon Terry | Chief Operating Officer | 02/12/2021 | 162,435 |
Sukhtian Ghiath M. | Director | 02/10/2021 | 1,013,627 |
Syntone Ventures LLC | 10% Owner | 02/03/2021 | 3,000,000 |
Sukhtian Ghiath M. | Director | 02/02/2021 | 8,360,000 |
Haddadin Yezan Munther | Director | 09/22/2020 | 7,245 |
Sukhtian Faisal Ghiath | Director | 09/17/2020 | 6,731 |
THURMAN RANDY H | Director | 09/14/2020 | 6,200 |
Syntone Ventures LLC | 10% Owner | 07/15/2020 | 1,000,000 |
Sukhtian Ghiath M. | Director | 02/26/2020 | 2,500,000 |
BioLexis Pte Ltd. | Director | 01/29/2020 | 1,080,622 |
BioLexis Pte Ltd. | Director | 12/23/2019 | 674,909 |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | 09/18/2019 | 2,295 |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | 09/18/2019 | 2,295 |
BioLexis Pte Ltd. | Director | 04/12/2019 | 10,000,001 |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | 02/07/2019 | 22,380 |
HILZINGER KURT J | Director | 02/04/2019 | 4,786 |
BioLexis Pte Ltd. | Director | 02/01/2019 | 4,000,000 |
HILZINGER KURT J | Director | 01/31/2019 | 4,725 |
HILZINGER KURT J | Director | 01/30/2019 | 3,521 |
HILZINGER KURT J | Director | 02/01/2019 | 6,314 |
HILZINGER KURT J | Director | 01/29/2019 | 3,942 |
HILZINGER KURT J | Director | 01/28/2019 | 11,278 |
HILZINGER KURT J | Director | 01/25/2019 | 7,471 |
HILZINGER KURT J | Director | 01/23/2019 | 1,518 |
HILZINGER KURT J | Director | 01/22/2019 | 7,309 |
HILZINGER KURT J | Director | 01/17/2019 | 1,587 |
HILZINGER KURT J | Director | 01/16/2019 | 544 |
Mohan Pankaj | Director | 01/15/2019 | 5,440 |
HILZINGER KURT J | Director | 01/15/2019 | 1,586 |
HILZINGER KURT J | Director | 01/14/2019 | 3,123 |
HILZINGER KURT J | Director | 01/09/2019 | 2,038 |
HILZINGER KURT J | Director | 01/10/2019 | 4,237 |
HILZINGER KURT J | Director | 01/08/2019 | 4,166 |
HILZINGER KURT J | Director | 01/07/2019 | 3,255 |
HILZINGER KURT J | Director | 01/04/2019 | 3,661 |
HILZINGER KURT J | Director | 01/02/2019 | 968 |
HILZINGER KURT J | Director | 12/31/2018 | 6,696 |
HILZINGER KURT J | Director | 01/03/2019 | 2,478 |
BioLexis Pte Ltd. | Director | 01/02/2019 | 4,000,000 |
HILZINGER KURT J | Director | 12/28/2018 | 6,193 |
HILZINGER KURT J | Director | 12/27/2018 | 372 |
HILZINGER KURT J | Director | 12/26/2018 | 3,086 |
HILZINGER KURT J | Director | 12/24/2018 | 735 |
HILZINGER KURT J | Director | 12/21/2018 | 2,340 |
THURMAN RANDY H | Director | 12/21/2018 | 10,251 |
BioLexis Pte Ltd. | Director | 12/03/2018 | 4,000,000 |
BioLexis Pte Ltd. | Director | 11/07/2018 | 7,999,999 |
KENYON LAWRENCE A | CEO, Pres, CFO, Treas & Secy | 09/18/2018 | 8,807 |
Bahrt Kenneth | Chief Medical Officer | 06/25/2018 | 6,507 |
GMS Tenshi Holdings Pte. Ltd | Director | 05/14/2018 | 6,217,949 |
GMS Tenshi Holdings Pte. Ltd | Director | 06/08/2018 | 6,217,949 |
Mohan Pankaj | President & CEO | 01/04/2018 | 72,580 |
Mohan Pankaj | President & CEO | 01/03/2018 | 61,487 |
Yamashita Elizabeth A. | VP, Regulatory Affairs | 12/22/2017 | 18,272 |
Bahrt Kenneth | Chief Medical Officer | 12/22/2017 | 29,566 |
MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | 12/22/2017 | 17,747 |
KENYON LAWRENCE A | CFO and Secretary | 12/22/2017 | 29,566 |
Mohan Pankaj | President & CEO | 12/19/2017 | 95,313 |
Mohan Pankaj | President & CEO | 12/18/2017 | 24,012 |
Yamashita Elizabeth A. | VP, Regulatory Affairs | 12/19/2017 | 7,012 |
Yamashita Elizabeth A. | VP, Regulatory Affairs | 12/18/2017 | 1,766 |
HILZINGER KURT J | Director | 01/23/2017 | 120 |
Griffith Donald J. | Director | 11/23/2016 | 4 |
Gangloff Scott A. | SVP, Development & Mfrg | 11/11/2016 | 140,134 |
MCANDREW STEPHEN J | SVP Bus. Strat. & Dev. | 11/11/2016 | 80,126 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 10,366,285 | 0.0001% | 10.36% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 2,970,346 | 0.00012% | 6.71% | Other |
RENAISSANCE TECHNOLOGIES LLC | 105,418 | 0.00007% | New | Other |
FISHER ASSET MANAGEMENT, LLC | 12,476 | 0.00001% | Exited | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View